Know Cancer

or
forgot password
  • cancer clinical trials in los angeles, CA

  • BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    Good Samaritan Hospital

    Trial Locations
    Good Samaritan Hospital
    UCLA Med - Hematology & Oncology
    Renal Cell Carcinoma
    A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)
    UCLA Medical Center
    Los Angeles, California 90095-7059
    Gastrointestinal Stromal Tumor
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    Children's Hospital Los Angeles
    Los Angeles, California 90027-0700
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Los Angeles, California 90048-1865
    Lung Cancer
    I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
    University of Southern California
    Los Angeles, California 90033
    Breast Neoplasms, Breast Cancer, Breast Tumors
    Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)
    USC/Norris Comprehensive Cancer Center
    Los Angeles, California 90033-0800
    Gastro-Intestinal Cancer
    Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways
    UCLA Jonsson Comprehensive Cancer Center
    Los Angeles, California 90095
    Lung Cancer
    Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients
    UCLA Jonsson Comprehensive Cancer Center
    Los Angeles, California 90095
    Breast Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Children's Hospital Los Angeles

    Trial Locations
    Children's Hospital Los Angeles
    David Geffen School of Medicine at UCLA
    Mattel Children's Hospital UCLA
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Survey of Inhibitors in Plasma-Product Exposed Toddlers
    Childrens Hospital Los Angeles
    Los Angeles, California 90027
    Hemophilia A
    Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
    University of Southern California
    Los Angeles, California 90033
    Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    City of Hope National Medical Center
    University of Southern California
    Pancreatic Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    University of Southern California

    Trial Locations
    University of Southern California
    Los Angeles County-USC Medical Center
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
    Children's Hospital Los Angeles
    Los Angeles, California 90027-0700
    Childhood Low-grade Cerebellar Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Childhood Mixed Glioma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma
    An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
    UCLA
    Los Angeles, California 90095
    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Acute Myeloid Leukemia, Multiple Myeloma
    Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
    West Los Angeles VA Medical Center
    Los Angeles, California 90073
    Multiple Myeloma
    Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    University of Southern California
    Los Angeles, California 90033
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    Children's Hospital Los Angeles
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    University of California at Los Angeles (UCLA )
    Los Angeles, California 90095
    Breast Cancer
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Los Angeles, California 90048-1865
    Cervical Cancer
    Aplidin - Dexamethasone in Relapsed/Refractory Myeloma
    UCLA Medical School
    Los Angeles, California 90095-1670
    Relapsed/Refractory Multiple Myeloma
    Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer
    University of Southern California
    Los Angeles, California 90033
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
    University of California at Los Angeles UCLA LeConte Location
    Los Angeles, California 90095
    Advanced Solid Tumors, Recurrent or Refractory Medulloblastoma, Locally Advanced or Metastatic Basal Cell Carcinoma
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    City of Hope National Medical Center
    Los Angeles, California 91010
    Chronic GVHD
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    City of Hope National Medical Center
    Multiple Myeloma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    USC & Norris Cancer Center
    Los Angeles, California
    Peripheral T-cell Lymphoma
    A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
    Site Reference ID/Investigator# 25034
    Los Angeles, California 90048
    Ovarian Cancer
    Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
    Cedars-Sinai Medical Center
    Los Angeles, California 90048
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Ovarian Endometrioid Adenocarcinoma, Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Triple-negative Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Kaiser Permanente Medical Center - Los Angeles

    Trial Locations
    Kaiser Permanente Medical Center - Los Angeles
    USC/Norris Comprehensive Cancer Center and Hospital
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Kaiser Permanente Medical Group
    Kaiser Foundation Hospital - West Los Angeles
    Kidney Cancer
    Childhood Cancer Survivor Study
    University of California-Los Angeles
    Los Angeles, California 90095
    Cancer
    First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
    Ucla-Division Of Hematology/Oncology

    Trial Locations
    Ucla-Division Of Hematology/Oncology
    Usc - Norris Comprehensive Cancer Center And Hospital
    Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma
    Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
    Site Reference ID/Investigator# 26742
    Los Angeles, California 90033
    Gastric Cancer
    A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)
    Cancer Care Institute

    Trial Locations
    Cancer Care Institute
    White Memorial Medical Center
    Metastatic Pancreatic Adenocarcinoma
    Study of Denileukin Diftitox in Patients With Stage IIIC and Stage IV Melanoma
    The Angeles Clinic and Research Institute
    Los Angeles, California 90025
    Stage IIIC Melanoma, Stage IV Melanoma
    Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector
    Mattel Children's Hospital - UCLA
    Los Angeles, California 90095
    Severe Combined Immunodeficiency
    Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
    University of California at Los Angeles UCLA LeConte Location
    Los Angeles, California 90095
    Metastatic Breast Cancer, Trastuzumab, BKM120, HER2+
    Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
    Cedars Sinai Medical Center

    Trial Locations
    Cedars Sinai Medical Center
    University of California at Los Angeles
    Cedars Sinai Medical Center Dept. of Pituitary Ctr.
    Acromegaly